Published on May 18, 2009 at 4:58 PM
A new report issued today by HHS' Agency for Healthcare Research and Quality found that there isn't enough evidence to determine which drugs work best to treat erectile dysfunction and which cause the least harm. Erectile dysfunction is a common sexual disorder that prevents men from getting or keeping an erection. It affects between 15 million and 30 million men in the United States.
The authors found that men who took oral phosphodiesterase type 5 inhibitors (also known as PDE-5 inhibitors) had improved erectile function as compared to men who didn't take the medication. However, head-to-head trials comparing three erectile function medications - sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis) -- were inconclusive as to which medication worked best.
The most common short-term side effects in men taking PDE-5 inhibitors were headache, flushing, abdominal pain, and runny nose, and although the types of reactions varied with the drugs studied, there were no significant differences in side effects associated with either Viagra, Levitra, or Cialis.
According to Alexander Tsertsvadze, M.D. of the AHRQ-supported University of Ottawa Evidence-based Practice Center, who led the review, more studies are needed to clarify the best treatment management options for different groups of patients as well as more clinical trials to compare PDE-5 inhibitors to hormonal, injection, and creams or other topical treatments for erectile dysfunction.
For a copy of Diagnosis and Treatment of Erectile Dysfunction go to http://www.ahrq.gov/downloads/pub/evidence/pdf/erectiledys/erecdys.pdf.
http://www.ahrq.gov